MED-G-200

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameMED-G-200

Drug Alias Nameliposomic labdane diterpenes (Medexis)liposome-encapsulated cell cycle inhibitors (Medexis)liposomic labdane diterpenes (Medexis)MED-G-200

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionCell cycle inhibitorsApoptosis stimulants

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGreece

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity of Athens

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedexis Biotech SA

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A